Interview with Jan-Willem Eleveld, Vice President, Counsulting & Services,…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Address: 302, Level 3, Damansara Uptown 2, 2 Jalan SS21/37, 47400 Petaling Jaya, Selangor,Malaysia
Tel: 603 7710 7380
Web: http://www.imshealth.com/portal/site/ims
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Commercial Implementation Services: We help meet the challenges of commercial information management, with cutting-edge solutions in reporting and analytics, and operations and compensation outsourcing.
Managed Markets Services: With more than three-quarters of U.S. prescriptions underwritten by third-party payers, we’re the ones to call to help meet contracting, compliance and systems challenges.
Market Research Services: We not only deliver views of market position, but also provide related services — including outsourcing of key market research processes.
We apply Evidence-Based ConsultingSM that can have an immediate impact on the business and market performance of our clients. We help to strengthen portfolios, optimize product launches, mount superior marketing efforts, forge more productive alliances and optimize sales force structure and deployment.
Product & Portfolio Strategy
Companies that don’t plan for the future don’t have one. We help keep the compass pointed in the right direction.
Commercial Effectiveness
A surprisingly low percentage of pharmaceutical brands outperform expectations. We help clients gain access to that elite club.
Pricing & Market Access
There’s both an art and a science to launching new products and ensuring optimal market access and price. We understand the complex dynamics shaping the prospects for products in research and development as well as for those already in-market.
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Jennifer Lopez, executive director of the British Malaysian Chamber of Commerce, discusses foreign investment trends in Malaysia and how the chamber is serving its members, especially UK companies operating in…
Lim Teng Chyuan, president of the Malaysian Association for Pharmaceutical Suppliers (MAPS), discusses the association’s role in solving and supporting its members with the numerous regulatory issues and compliance requirements…
Amrahi Buang, president of the Malaysian Pharmaceutical Society details the ‘lack’ of recognition and integration of pharmacists in Malaysia. He also explains the complex dual healthcare system and the governmental…
The managing director of Boston Consulting Group Malaysia discusses the gap between public and private healthcare in the country, and what can be done to bridge it. What appears…
Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region…
Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable quality healthcare in a country that is naturally diverse as…
Klaus Boehncke and Yennie Tan from PwC Malaysia discuss the factors that will make the country a hub for medical tourism and the importance of listening to patient demands at…
Dr. Hassan, founder and CEO of Healwell and House of Healin, brings research and entrepreneurship together with the aim of turning Malaysian traditions into scientific innovation. Could you share…
Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s…
Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in…
Sanofi’s general manager for Malaysia, Singpoare and Brunei discusses the benefits of implementing of a new channel business model and proudly showcases the dengue vaccine, 20 years after the company initiated…
See our Cookie Privacy Policy Here